Endpoints
Sanifit Announces the Phase 2b CaLIPSO Trial of SNF472 Met Endpoint in Slowing the Cardiovascular Calcification in Patients on Hemodialysis
Nice Insight
PR-M10-19-NI-051Nov 01, 2019
Phase II Study
Sanifit Announces Completion of Enrollment in CaLIPSO - its Phase 2b Study for the Treatment of Cardiovascular Calcification in End-Stage-Renal-Disease Patients on Haemodialysis
Sanifit
PR-M08-18-NI-067Aug 16, 2018